Sergio Ferra-Murcia

5PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Impact of Switching from Oral to Long-Acting Injectable Cabotegravir and Rilpivirine on the Lipid Profile of HIV-Positive Patients.

Marta Segura Díaz, Antonio Collado Romacho, Sergio Ferra Murcia

|Feb 24, 2024
DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain.

Sergio Sequera-Arquelladas, Carmen Hidalgo-Tenorio, Luis López-Cortés

|Sep 07, 2022
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study).

Cristina Gómez-Ayerbe, Rosario Palacios, Marisa Mayorga

|May 14, 2022
Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection.

Sergio Ferra-Murcia, Antonio Ramón Collado-Romacho, Bruno José Nievas-Soriano

|Mar 26, 2022
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).

Carmen Hidalgo-Tenorio, Juan Pasquau, David Vinuesa

Pageof 1

Frequent Collaborators

2 joint publications

Antonio Ramón Collado-Romacho

1 joint publications

Carmen Hidalgo-Tenorio

1 joint publications

José Ramón Blanco

1 joint publications

Marta Montero